On June 22, 2023, Theraclion SA closed the transaction. the company issued 14,478,269 ABSAs, new shares with warrants attached, each with a par value of of â¬0.577 for the gross proceeds of of â¬8,353,961.213 along with additional warrants of of â¬1,300,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.36 EUR | -1.10% | +4.35% | -7.22% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.22% | 17.42M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- ALTHE Stock
- News Theraclion
- Theraclion SA announced that it has received €8.353961 million in funding from Furui Medical Science Company Luxembourg S.à r.l.